Sader, H.S.; Mendes, R.E.; Kimbrough, J.H.; Hubler, C.M.; Castanheira, M.
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients. Antibiotics 2024, 13, 564.
https://doi.org/10.3390/antibiotics13060564
AMA Style
Sader HS, Mendes RE, Kimbrough JH, Hubler CM, Castanheira M.
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients. Antibiotics. 2024; 13(6):564.
https://doi.org/10.3390/antibiotics13060564
Chicago/Turabian Style
Sader, Helio S., Rodrigo E. Mendes, John H. Kimbrough, Cory M. Hubler, and Mariana Castanheira.
2024. "Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients" Antibiotics 13, no. 6: 564.
https://doi.org/10.3390/antibiotics13060564
APA Style
Sader, H. S., Mendes, R. E., Kimbrough, J. H., Hubler, C. M., & Castanheira, M.
(2024). Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients. Antibiotics, 13(6), 564.
https://doi.org/10.3390/antibiotics13060564
